Central Nervous System and Therapeutics is on Jun 10 2019 at Edinburgh

Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme

Reviving Innovations in Treatment of CNS Disorders

- CNS 2019

Welcome Message

After the grand success of CNS 2018, We enthusiastically and expectantly invites you all for the “2nd International Conference on Central Nervous System and Therapeutics” which s scheduled to be held on June 10-11, 2019, at Edinburgh, Scotland with the theme “Reviving Innovations in Treatment of CNS Disorders”.

This year we forecast more participants to interchange their valuable knowledge with the ingenious theme of “Reviving Innovations in Treatment of CNS Disorders”.

This is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists. The intending participants can confirm their participation by registering for the CNS conference along with your colleagues. This Conference will provide a forum for the exchange of ideas and authoritative views by leading scientists as well as business leaders and investors in this exciting field. Outstanding keynote speakers and well known leading scientists and experts from around the globe will be expected to share their knowledge at this CNS Summit.

Tie your hand with us to enhance your experiences on the theme of the conference and catalyze the future exchange of knowledge to develop and celebrate a new healthy world.

We have the pleasure to invite and welcome you for the participation to our exciting Central Nervous system (CNS) conference. Let us meet in one of the most glorious cities in the world.

Regards,
Organizing Committee

CNS 2019

We ebulliently and amiably invite all delegates, speakers, exhibitors, and sponsors from across the globe to participate in the 2nd International Conference on Central Nervous System and Therapeutics which is going to be held during June 10-11, 2019 at Edinburgh, Scotland

Who can attend?

Neurologists, Neurosurgeons, Neuro-oncologist, Neurophysiologists, Neuropsychologists, Neurologist, Neuroradiologist, Neuro-Pathologists, Rehabilitation Specialists, Nurses, Neuroscience Researchers and Students from academia in the research of CNS Disorders and Neurology. Directors, Head of Department, Professors, Industrial Researchers, Academicians, Scientists

Scientific session

Session on Central Nervous System Disorders

Central Nervous system(CNS) plays a major role in awareness, movements, sensations, thoughts, speech and memory. It is responsible for integrating sensory information and responding accordingly. The spinal cord serves as a conduit for signals between the brain and the rest of the body. It also controls simple musculoskeletal reflexes without input from the brain. The disorders that affect the brain and spinal cord are known as CNS Disorders. The global CNS therapeutic market is expected to reach USD 128.9 billion by 2025. The main aim of this CNS conference is to understand the parts of CNS and their disorders.

Related Conferences:

28th World Congress on Neurology and Therapeutics February 28 – March 01, 2019 Berlin, Germany;2nd Annual Congress on Advancements in Neurology and Neuroscience, Berlin, Germany, March 11-12, 2019; CNS Annual Meeting, March 23-26, San Francisco;6th Annual Meeting on Neurosurgery and Neurological Surgeons,May 22-23, 2019 London, UK; European Conference on Amsterdam, Netherlands, June 10-11, 2019, International conference on Central nervous system and Neurological Surgeons, June 17-18, 2019 London; 7th International Conference On Central Nervous System Disorders & Therapeutics, Osaka, Japan, June 21-22, 2019;

Related Associations:

European Federation of Neurological Association(EFNA), Brain and Spine Foundation, American Academy of Neurology, American Association of Neurological Surgeons, Bulgarian Society of Neurology, Spanish Society of Neurology, Stroke Association, International Brain Injury Association, British Neuroscience Associations.

Session on Cognitive Neurology

Cognitive neuroscience is the scientific field that is concerned with the study of the biological processes and aspects that underlie cognition, with a specific focus on the neural connections in the brain which are involved in mental processes. This session focuses on Introduction to Cognitive Neuroscience, Cognitive Assessment, Clinical Presentation, Treatment, and Management Issues.

Related Conferences:

Behavioral neuroscience is the study of the brain mechanisms underlying behavior. This is important for understanding how the normal brain works to support cognition, emotion and sensorimotor function. Two fields associated with behavioral neurology are neuropsychiatry and neuropsychology. This session will provide a deeper understanding on how and why things go wrong in the brain in various neurological and psychiatric disorders.

Related Conferences:

28th World Congress on Neurology and Therapeutics February 28 – March 01, 2019 Berlin, Germany;2nd Annual Congress on Advancements in Neurology and Neuroscience, Berlin, Germany, March 11-12, 2019; CNS Annual Meeting, March 23-26, San Francisco;6th Annual Meeting on Neurosurgery and Neurological Surgeons,May 22-23, 2019 London, UK; European Conference on Amsterdam, Netherlands, June 10-11, 2019, International conference on Central nervous system and Neurological Surgeons, June 17-18, 2019 London; 7th International Conference On Central Nervous System Disorders & Therapeutics, Osaka, Japan, June 21-22, 2019;

Related Associations:

American Neuropsychiatric Association and the BehaviouralNeurology Society, Swiss Society for Behavioural Neurology, Society for Behavioural and Cognitive Neurology (SBCN), International Society for Behavioural Neuroscience.

Session on Neurodegenerative Disorders

Neurodegenerative disorders are the conditions that result in degeneration or death of the nerve cells. This causes problems with mental function (called dementia's) or movement (called ataxia). It can be severe or life-threatening. It depends upon the type. Most of them are incurable. Treatments may help to improve symptoms, increase mobility and relieve pain.

Session on Spinal Cord Disorders

Spinal cord disorders cause various patterns of deficits depending on which nerve tracts within the cord or which spinal roots outside the cord are damaged. Disorders affecting spinal nerves, but not directly affecting the cord, cause sensory or motor abnormalities or both only in the areas supplied by the affected spinal nerves. Spinal cord disorders can cause permanent severe neurologic disability. For some patients, such disability can be avoided or minimized if evaluation and treatment are rapid.

Related Conferences:

Related Associations:

International Spinal Cord Society, American Spinal InjuryAssociation, Spinal Cord Society, North American Spine Society, International Society for Advancement of Spine Surgeries, The Australian and New Zealand penal Cord Society, Spinal Cord Injuries Australia.

Session on CNS Biomarkers

Biomarkers are important tools for understanding disease mechanism, developing more effective treatments, and improving the quality of patient care. The discovery of biomarkers for CNS disorders has gained considerable interest within the pharmaceutical industry due to the many unmet needs in current treatments and diagnostics. Here we discuss the role of CNS biomarkers in early discovery, in drug development, and for future diagnostics. We also discuss the different disease segments, describing gaps in treatment and limitations of current methods of diagnosis. This session also addresses the growth drivers and growth inhibitors that can affect CNS biomarker adoption.

Related:

Session on Neurodevelopmental Disorders

The disability associated with the functioning of the neurological system and brain is known as Neurodevelopmental disorders. People with neurodevelopmental disorders can experience difficulties with speech and language, behavior, motor skills, memory, learning, and other neurological function. Evaluation and treatment of these disorders are difficult. Treatment involves a combination of pharmaceuticals, professional therapy, and home-school-based programs.

Related:

Related Associations:

Neurodevelopmental and Behavioural Paediatric Society of Australasia (NBPSA), The International Parkinson and Movement Disorder Society (MDS), Autism Society of British Columbia.

Session on Cerebrovascular Disease

The disease that affects the blood vessels of the brain and the cerebral circulation is known as Cerebrovascular Disease. These diseases are subdivided into ischemic events and cerebral hemorrhages. This session focuses on the diagnosis, treatment, and prognosis of the cerebrovascular disease.

Related Conferences:

Related Associations:

Shropshire Cerebral Palsy Society, Cerebrals Society, Cerebral Palsy Society of New Zealand, The Cerebral Palsy Association of Manitoba, Greensboro Cerebral Palsy Association, United Cerebral PalsyAssociation.

Session on Neuropharmacology

The study of drugs that affect cellular functions in the neural mechanisms and nervous system, through which they influence behavior is known as Neuropharmacology. Molecular neuropharmacology involves the study of neurons and their neurochemical interactions with the overall motive of developing new drugs that have beneficial effects on the nervous system. This session focuses on the alteration in psychiatric diseases, neuromodulation and the recent Drug development in the field of Neurological Disorders.

Related Associations:

European Society for Clinical Neuropharmacology, Society on Neuroimmune Pharmacology, Association for Clinical Pharmacology and Therapeutics, International Society of Neuroimmunology, British Association of Psychopharmacology, Japanese Society of Neuropsychopharmacology, British Pharmacological Society.

Session on Neurochemical Transmission

A Neuron imparts its electrical movement to different cells by discharging chemicals at the Junction of the two cells, that procedure is known as Neurochemical transmission. Chemical transmission is the major means by which nerves communicate with one another in the nervous system. The compound substances which exchange an electrical drive from a nerve cell to its objective cell are known as neurotransmitters.

Related Associations:

International society for neurochemistry, Society for Neurochemistry India, American Society for Neurochemistry, Asian-PacificSociety for Neurochemistry, American Association of Neurological Surgeons, American Academy of Neurology, The Japanese Society for Neurochemistry.

Session on Neuro-Oncology

Neuro-oncology is the study of brain and spinal cord neoplasms, many of which are life-threatening and are dangerous. Among the malignant brain cancers, gliomas of the brainstem and pons, glioblastoma multiforme, and high-grade astrocytoma are the worst. This session focuses on the diagnosis and treatments of Brain Tumour and Cancer.

Related Associations:

Society for Neuro-Oncology, Asian Society for Neuro-Oncology, European Association of Neuro-Oncology, American Academy of Neurology, American Association of Neurological Surgeons, British Neuro-oncology Society, International Brain Tumour Alliance.

Session on Neurogenesis

The process by which neurons or nerve cells are generated in the brain is known as Neurogenesis. It is most active during the early stage of development when a baby's brain is being formed. During adulthood, new neurons are generated at a much slower pace than during prenatal development.

Related Conferences:

Related Associations:

European Society of Human Genetics, The British Neuroscience Association, Austrian Neuroscience Association, The American Association of Immunologists, Polish Neuroscience Society, British Society for Immunology.

Session on Neuropsychiatric disorders

Neuropsychiatry is a combination of both Psychiatry and Neurology which focuses on disorders related to mental health. Neuropsychiatric conditions are mental disorders that are typically related to diseases that originate from the nervous system. These diseases affect the ability to learn, work, and emotionally cope. Researchers in this field are making a great effort in determining the biological basis on these diseases. Neuropsychiatrist works along with additional Neuroscience clinicians, namely neurosurgeon, and neurologist, to deliver complete care to the patients.

Related Conferences:

Related Associations:

American Neuropsychiatric Association, Association of Psychology and Psychiatry for Adults and Children, British NeuropsychiatryAssociation, Alzheimer’s Association, International NeuropsychiatricAssociation, American Academy of Sleep Medicine, World Psychiatric Association.

Session on Neurosurgery

Neurosurgery refers to the medical specialty dedicated to the diagnosis, prevention, treatment, and rehabilitation of disorders that affect our nervous system i.e., brain, spinal cord, peripheral nerves, and extra-cranial cerebrovascular system. Developed in the first half of the twentieth-century neurosurgery has witnessed till date exponential advances in intensive care, technology, and sophisticated non-invasive procedures. This has undoubtedly have widened the scope of neurosurgical practice. Pediatric neurosurgery, Functional Neurosurgery, Neurovascular Surgery, Traumatology, Neuro-oncology, Skull-base surgery, Spinal surgery are the different categories of neurosurgery.

Related Conferences:

Related Associations:

American Academy of Neurology, Society of British Neurological Surgeons, American Association of Neurological Surgeons, European Association of Neurosurgical Societies, American Society for Stereotactic and Functional Neurosurgery.

Session on Paediatric Neurology

The branch of medicine that deals with the management and diagnosis of neurological conditions in children, infants, neonates, and adolescents is known as pediatric neurology. The discipline of child neurology encompasses diseases and disorders of the brain, spinal cord, autonomic nervous system, peripheral nervous system, and blood vessels that affects individuals in these age groups too.A pediatric neurologist has a specialized knowledge on assess, diagnose, training and treatment of the children affected with nervous disorders. The conditions deal with by pediatric neurologists vary considerably, from relative disorders such as cerebral palsy or a migraine through to more complex and rare conditions such as neurodegenerative disorders or metabolic disease.

Related Associations:

American Paediatric Society, Belgian Society of PaediatricNeurology, Child Neurology Society, European Paediatric Neurology Society, Canadian Association of Child Neurology, Asia Pacific Paediatric Association, Infantile Seizure Society.

Session on Computational Neuroscience

Computational neuroscience is the field of study in which theories and mathematical tools are used to investigate brain function. It can also incorporate diverse approaches from computer science, physics and electrical engineering, in order to understand how the nervous system processes information.

Session on Neuropathology

The branch of medicine concerned with the disease of the nervous system is known as Neuropathology. This field deals with the study of diseases related to nervous system tissue, usually in the form of either small whole autopsies or surgical biopsies. It is a subspecialty of neurology, anatomic pathology, and neurosurgery. Diseases with diverse genetic and etiologic features have very similar pathological and Clinical characteristics.

Related Conferences:

Related Associations:

The International Society of Neuropathology, The Japanese Society of Neuropathology, American Associations of Neuropathologists, British Neuropathological Society, Canadian Association of Neuropathologists.

Session on Neuromuscular Disorders

Neuromuscular disorders are disorders of the nerves that control the voluntary muscles. One of the causes is the immune system disorder and genetic. More than 2 million people in the United States are affected by such a form of neuromuscular diseases and about 30% of them are under the age18. Diagnosis includes NCV test, biochemical, genetic test, a multi-step process like muscle biopsy etc. The motive of this session is to understand the origin of Muscular dystrophy, Lambert-Eaton syndrome and neuromuscular junction disorder. Further, there will be an interactive conversation on Hyperreflexia, Spasticity and its prevention.

Session on Neuroplasticity

Neuroplasticity also known as brain plasticity. It is an umbrella term that encompasses both non-synaptic plasticity and synaptic plasticity. It refers to change in synapses and neural pathways due to changes in the environment, neural processes, thinking, behavior and emotions. The main aim of this session is to understand the neuroplasticity, advances in the Neurite remodeling and How to increase Neural-Connections.

Market Analysis

Further Key Findings from the Report Suggest:

Global mental health therapeutics revenue accounted for 48% share in 2016 and is expected to grow at a significant rate from 2016 to 2025

Global demand for the treatment of Parkinson’s and Alzheimer’s diseases is anticipated to witness extensive growth over the next 9 years

The industry in the Asia Pacific is expected to report the fastest growth over the forecast period owing to various developments across major economies of the region, especially in the mental health sector.

Key players including Pfizer, Inc.; Teva Pharmaceutical Industries Ltd.; Biogen, Inc.; Johnson & Johnson Services, Inc.; Eli Lilly and Company; and Novartis AG led the global CNS disease treatment market by capturing a majority share.

CNS therapeutics market, by disease (USD Millions)

CNS Therapeutics Regional Outlook (Revenue, USD Million, 2014 - 2025)

North America

Canada

Europe

Germany

Asia Pacific

India

Japan

Latin America

Brazil

Mexico

Middle East and Africa

South Africa

Companies Mentioned Include:

GlaxoSmithKline

Pfizer

Eli Lilly

Abital Pharma

Aprecia Pharmaceuticals

Archer Pharmaceuticals

MSI Methylation Sciences

Mylan

Opexa

Opko Health

Par Pharmaceuticals

SAGE Therapeutics

Sanofi

US WorldMeds

Valeant Pharmaceuticals

Zinfandel Pharmaceuticals

Zogenix

Top Hospital in the World:

Mayo Clinic, Rochester, Minnesota

New York–Presbyterian University Hospital of Columbia and Cornell, New York City

Johns Hopkins Hospital, Baltimore, Maryland

Massachusetts General Hospital, Boston

University of California–San Francisco Medical Center

Cleveland Clinic, Ohio

University of California–Los Angeles Medical Center

New York University Langone Medical Center, New York City

Hospitals of the University of Pennsylvania–Penn Presbyterian

Northwestern Memorial Hospital, Chicago

Top Hospital in the Country:

Golden Jubilee National Hospital

The State Hospital

Dr. Gray’s Hospital

Aberdeen Maternity Hospital

St John's Hospital at Howden

Chalmers Hospital

Belford Hospital

Vale of Leven District Hospital

Ayr Hospital

Arran War Memorial Hospital

Top Universities around the world

University of California

University of Oxford

Columbia University

Massachusetts Institute of Technology

University of California

University College London

Stanford University

Harvard University

Past Conference Report

First of all, we extend our thanks to all of our excellent keynotes, speakers, conference attendees, students, associations, media partners, exhibitor and guests who made this CNS 2018 Conference as most successful and victorious event.

AAC hosted the event The International Conference on Central Nervous System and Therapeutics during November 10-11, 2018 at Hôtel l'Élysée Val d'Europe with the theme “Recent advances and diagnosis in CNS treatment”. Benevolent and active participation from the Editorial Board Members of supporting International Journals as well as from the leading academic researchers, Neurologists, Doctors, research scholars, students and leaders from the fields of CNS are the cause to make this event successful.

The CNS Conference was marked by the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 18 countries, who have driven this event into the path of success. The conference highlighted through various sessions on current retroviral research.

CNS 2018 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the fields CNS disorders, Neuroscience, Neuro-Oncology, Neuro-rehabilitation, CNS Biomarkers etc.,

The CNS Conference proceedings were carried out through various Scientific-sessions and plenary lectures. The conference was embarked with an opening ceremony followed by a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk and testimonials received from the attendees were;

Keynotes and Speakers at CNS 2018:

Karl Sterling | PhysioChains LLC | USA

Alessandro Morelli | University of Genova | Italy

Gustavo Balthazar Da Silveira Carvalho | Federal University of Sao Paulo | Brazil

Birendra K Bista | Neuro Cardio and Multispecialty Hospital | Nepal

Jose Carlos Rodrigues Junior | Heliópolis Hospital | Brazil

Venkataramana Pamidimukkala | Sevenhills Hospital | India

With the grand success of CNS 2018, AAC proud to announce the "2nd International Conference on Central Nervous System and Therapeutics” is slated to be held during June 10-11, 2019 in Edinburgh, Scotland.

For more information please visit: http://cns.alliedacademies.com

For more information please visit CNS 2018 Past Conference Report page: Click Here

To visit CNS 2018 Conference Book Proceedings: ClickHere

Organizing Committee

Jose Carlos Rodrigues Junior

Head of Service of Neurosurgery , Neurosurgery, Vascular Neurosurgery

Heliópolis Hospital

Sao Paulo, Brazil

Tamara C. McGill-Carter

Neurodevelopmental Specialist

The Chicago School of Professional Psychology

Chicago, USA

Dr.Rajendra D. Badgaiyan

Professor, psychiatry and cognitive neuroscience

Icahn School of Medicine at Mount Sinai

New York, USA

To Collaborate Scientific Professionals around the World

Conference Date	June 10-11, 2019
Speaker Oppurtunity
Poster Oppurtunity	Available
e-Poster Oppurtunity	Available
Sponsorship Opportunities	Click here for Sponsorship Opportunities